Respiratory syncytial virus PREVENT Study questions.
Moler
F W
FW
D006760:Hospitalization; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D007223:Infant; D018357:Respiratory Syncytial Virus Infections / Q000401:mortality / Q000517:prevention & control*
D016756:Immunoglobulins, Intravenous; C098685:respiratory syncytial virus immune globulin intravenous